Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 1,113

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.

Obesity

González-Muniesa, Pedro, Mártinez-González, Miguel-Angel, Hu, Frank B., Després, Jean-Pierre, Matsuzawa, Yuji, Loos, Ruth J. F., Moreno, Luis A., Bray, George A., Martinez, J. Alfredo·2017·Nature Reviews Disease Primers

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nrdp.2017.34

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 179

  1. Williams, E. P., Mesidor, M., Winters, K., Dubbert, P. M. & Wyatt, S. B. Overweight and obesity: prevalence, consequences, and causes of a growing public health problem. Curr. Obes. Rep. 4, 363–370 (2015). · DOI · Paper page
  2. Alberti, K. G. et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120, 1640–1645 (2009). · DOI · Paper page
  3. Sellayah, D., Cagampang, F. R. & Cox, R. D. On the evolutionary origins of obesity: a new hypothesis. Endocrinology 155, 1573–1588 (2014). · DOI
  4. Bhupathiraju, S. N. & Hu, F. B. Epidemiology of obesity and diabetes and their cardiovascular complications. Circ. Res. 118, 1723–1735 (2016). · DOI
  5. Martinez, J. A. Body-weight regulation: causes of obesity. Proc. Nutr. Soc. 59, 337–345 (2000). · DOI
  6. Heymsfield, S. B. et al. Multi-component molecular-level body composition reference methods: evolving concepts and future directions. Obes. Rev. 16, 282–294 (2015). This paper suggests that the methods traditionally used to diagnose obesity have been underestimating the problem, but more precise tools are under study and in development. · DOI · Paper page
  7. Seabolt, L. A., Welch, E. B. & Silver, H. J. Imaging methods for analyzing body composition in human obesity and cardiometabolic disease. Ann. NY Acad. Sci. 1353, 41–59 (2015). · DOI
  8. Fosbol, M. O. & Zerahn, B. Contemporary methods of body composition measurement. Clin. Physiol. Funct. Imaging 35, 81–97 (2015). · DOI
  9. Javed, A. et al. Diagnostic performance of body mass index to identify obesity as defined by body adiposity in children and adolescents: a systematic review and meta-analysis. Pediatr. Obes. 10, 234–244 (2015). · DOI · Paper page
  10. Cerhan, J. R. et al. A pooled analysis of waist circumference and mortality in 650,000 adults. Mayo Clin. Proc. 89, 335–345 (2014). · DOI · Paper page
  11. Sahakyan, K. R. et al. Normal-weight central obesity: implications for total and cardiovascular mortality. Ann. Intern. Med. 163, 827–835 (2015). · DOI
  12. Urdampilleta, A., Gonzalez-Muniesa, P., Portillo, M. P. & Martinez, J. A. Usefulness of combining intermittent hypoxia and physical exercise in the treatment of obesity. J. Physiol. Biochem. 68, 289–304 (2012). · DOI
  13. Dobbs, R. et al. How the world could better fight obesity (McKinsey Global Institute, 2014).
  14. Cornelsen, L., Green, R., Dangour, A. & Smith, R. Why fat taxes won’t make us thin. J. Public Health (Oxf.) 37, 18–23 (2015). · DOI
  15. Malik, V. S., Willett, W. C. & Hu, F. B. Global obesity: trends, risk factors and policy implications. Nat. Rev. Endocrinol. 9, 13–27 (2013). · DOI · Paper page
  16. Lauby-Secretan, B. et al. Body fatness and cancer — viewpoint of the IARC Working Group. N. Engl. J. Med. 375, 794–798 (2016). These data indicate a causal cancer-preventive effect of intentional weight loss. · DOI · Paper page
  17. Ng, M. et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 384, 766–781 (2014). · DOI · Paper page
  18. Yang, L. & Colditz, G. A. Prevalence of overweight and obesity in the United States, 2007–2012. JAMA Intern. Med. 175, 1412–1413 (2015). · DOI
  19. Nazare, J. A. et al. Ethnic influences on the relations between abdominal subcutaneous and visceral adiposity, liver fat, and cardiometabolic risk profile: the International Study of Prediction of Intra-Abdominal Adiposity and Its Relationship With Cardiometabolic Risk/Intra-Abdominal Adiposity. Am. J. Clin. Nutr. 96, 714–726 (2012). · DOI · Paper page
  20. Finkelstein, E. A. et al. Obesity and severe obesity forecasts through 2030. Am. J. Prev. Med. 42, 563–570 (2012). · DOI · Paper page
  21. Ahmad, O. B. et al. Age standardization of rates: a new WHO standard (WHO, 2001).
  22. Ahluwalia, N. et al. Trends in overweight prevalence among 11-, 13- and 15-year-olds in 25 countries in Europe, Canada and USA from 2002 to 2010. Eur. J. Public Health 25 (Suppl. 2), 28–32 (2015). · DOI
  23. Koletzko, B., Symonds, M. E. & Olsen, S. F. Programming research: where are we and where do we go from here? Am. J. Clin. Nutr. 94, 2036S–2043S (2011). · DOI
  24. Hanley, B. et al. Metabolic imprinting, programming and epigenetics — a review of present priorities and future opportunities. Br. J. Nutr. 104, S1–S25 (2010). · DOI
  25. Eriksson, J. G. Developmental origins of health and disease — from a small body size at birth to epigenetics. Ann. Med. 48, 456–467 (2016). · DOI
  26. Dearden, L. & Ozanne, S. E. Early life origins of metabolic disease: developmental programming of hypothalamic pathways controlling energy homeostasis. Front. Neuroendocrinol. 39, 3–16 (2015). · DOI
  27. Lin, X. et al. Developmental pathways to adiposity begin before birth and are influenced by genotype, prenatal environment and epigenome. BMC Med. 15, 50 (2017). · DOI
  28. Yu, Z. B. et al. Birth weight and subsequent risk of obesity: a systematic review and meta-analysis. Obes. Rev. 12, 525–542 (2011). · DOI
  29. Labayen, I. et al. Early life programming of abdominal adiposity in adolescents: the HELENA study. Diabetes Care 32, 2120–2122 (2009). · DOI
  30. Druet, C. et al. Prediction of childhood obesity by infancy weight gain: an individual-level meta-analysis. Paediatr. Perinat. Epidemiol. 26, 19–26 (2012). · DOI
  31. Chen, L. W. et al. Associations of maternal macronutrient intake during pregnancy with infant BMI peak characteristics and childhood BMI. Am. J. Clin. Nutr. 105, 705–713 (2017). · DOI
  32. Arenz, S., Ruckerl, R., Koletzko, B. & von Kries, R. Breast-feeding and childhood obesity — a systematic review. Int. J. Obes. Relat. Metab. Disord. 28, 1247–1256 (2004). · DOI · Paper page
  33. Weber, M. et al. Lower protein content in infant formula reduces BMI and obesity risk at school age: follow-up of a randomized trial. Am. J. Clin. Nutr. 99, 1041–1051 (2014). · DOI
  34. Ohlsson, C., Lorentzon, M., Norjavaara, E. & Kindblom, J. M. Age at adiposity rebound is associated with fat mass in young adult males — the GOOD study. PLoS ONE 7, e49404 (2012). · DOI
  35. Peneau, S. et al. Age at adiposity rebound: determinants and association with nutritional status and the metabolic syndrome at adulthood. Int. J. Obes. (Lond.) 40, 1150–1156 (2016). This paper suggests that monitoring childhood growth will help to identify children at risk of developing an adverse cardiometabolic profile in adulthood. · DOI
  36. Prentice, P. & Viner, R. M. Pubertal timing and adult obesity and cardiometabolic risk in women and men: a systematic review and meta-analysis. Int. J. Obes. (Lond.) 37, 1036–1043 (2013). · DOI · Paper page
  37. Hu, F. B. Obesity Epidemiology (Oxford Univ. Press, 2008).
  38. Hall, K. D. et al. Quantification of the effect of energy imbalance on bodyweight. Lancet 378, 826–837 (2011). · DOI · Paper page
  39. Vague, J. The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. Am. J. Clin. Nutr. 4, 20–34 (1956). · DOI · Paper page
  40. Saeed, S. et al. Genetic variants in LEP, LEPR, and MC4R explain 30% of severe obesity in children from a consanguineous population. Obesity (Silver Spring) 23, 1687–1695 (2015). · DOI
  41. Flier, J. S. Obesity wars: molecular progress confronts an expanding epidemic. Cell 116, 337–350 (2004). · DOI · Paper page
  42. Ferguson, L. R. et al. Guide and position of the International Society of Nutrigenetics/Nutrigenomics on personalised nutrition: part 1 — fields of precision nutrition. J. Nutrigenet. Nutrigenomics 9, 12–27 (2016).
  43. Ludwig, D. S. & Nestle, M. Can the food industry play a constructive role in the obesity epidemic? JAMA 300, 1808–1811 (2008). · DOI
  44. Bes-Rastrollo, M. et al. A prospective study of eating away-from-home meals and weight gain in a Mediterranean population: the SUN (Seguimiento Universidad de Navarra) cohort. Public Health Nutr. 13, 1356–1363 (2010). · DOI
  45. Sayon-Orea, C. et al. Association between sleeping hours and siesta and the risk of obesity: the SUN Mediterranean cohort. Obes. Facts 6, 337–347 (2013). · DOI
  46. Ludwig, D. S. Lifespan weighed down by diet. JAMA 315, 2269–2270 (2016). · DOI
  47. Jensen, M. D. et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and The Obesity Society. J. Am. Coll. Cardiol. 63, 2985–3023 (2014). · DOI · Paper page
  48. Martinez, J. A., Navas-Carretero, S., Saris, W. H. & Astrup, A. Personalized weight loss strategies-the role of macronutrient distribution. Nat. Rev. Endocrinol. 10, 749–760 (2014). This paper shows that the role of macronutrient distribution has to be considered for individualized dietary approaches. · DOI
  49. Razquin, C. et al. A 3 years follow-up of a Mediterranean diet rich in virgin olive oil is associated with high plasma antioxidant capacity and reduced body weight gain. Eur. J. Clin. Nutr. 63, 1387–1393 (2009). · DOI
  50. Estruch, R. et al. Effect of a high-fat Mediterranean diet on bodyweight and waist circumference: a prespecified secondary outcomes analysis of the PREDIMED randomised controlled trial. Lancet Diabetes Endocrinol. 4, 666–676 (2016). This paper shows that the Mediterranean diet (without calorie restriction) was associated with body weight loss and less gain in central adiposity. · DOI
  51. Mozaffarian, D. Food and weight gain: time to end our fear of fat. Lancet Diabetes Endocrinol. 4, 633–635 (2016). · DOI
  52. Cornier, M. A., Marshall, J. A., Hill, J. O., Maahs, D. M. & Eckel, R. H. Prevention of overweight/obesity as a strategy to optimize cardiovascular health. Circulation 124, 840–850 (2011). · DOI
  53. Nordestgaard, B. G. et al. The effect of elevated body mass index on ischemic heart disease risk: causal estimates from a Mendelian randomisation approach. PLoS Med. 9, e1001212 (2012). · DOI
  54. Park, M. H., Sovio, U., Viner, R. M., Hardy, R. J. & Kinra, S. Overweight in childhood, adolescence and adulthood and cardiovascular risk in later life: pooled analysis of three British birth cohorts. PLoS ONE 8, e70684 (2013). · DOI
  55. Renehan, A. G. et al. Incident cancer burden attributable to excess body mass index in 30 European countries. Int. J. Cancer 126, 692–702 (2010). · DOI
  56. Wang, Y. C., McPherson, K., Marsh, T., Gortmaker, S. L. & Brown, M. Health and economic burden of the projected obesity trends in the USA and the UK. Lancet 378, 815–825 (2011). · DOI · Paper page
  57. Jauch-Chara, K. & Oltmanns, K. M. Obesity — a neuropsychological disease? Systematic review and neuropsychological model. Prog. Neurobiol. 114, 84–101 (2014). · DOI
  58. Flegal, K. M., Kit, B. K., Orpana, H. & Graubard, B. I. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA 309, 71–82 (2013). · DOI · Paper page
  59. de Onis, M. & Lobstein, T. Defining obesity risk status in the general childhood population: which cut-offs should we use? Int. J. Pediatr. Obes. 5, 458–460 (2010). · DOI · Paper page
  60. Stokes, A. Using maximum weight to redefine body mass index categories in studies of the mortality risks of obesity. Popul. Health Metr. 12, 6 (2014). · DOI
  61. Elks, C. E. et al. Variability in the heritability of body mass index: a systematic review and meta-regression. Front. Endocrinol. (Lausanne) 3, 29 (2012).
  62. Meyers, M. G. Jr & Leibel, R. L. Lessons from rodent models of obesity. Endotexthttps://www.ncbi.nlm.nih.gov/books/NBK279123/ (updated 6 Sept 2015).
  63. van der Klaauw, A. A. & Farooqi, I. S. The hunger genes: pathways to obesity. Cell 161, 119–132 (2015). · DOI · Paper page
  64. Frayling, T. M. et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 316, 889–894 (2007). · DOI · Paper page
  65. Yang, J. et al. FTO genotype is associated with phenotypic variability of body mass index. Nature 490, 267–272 (2012). · DOI
  66. Milagro, F. I., Moreno-Aliaga, M. J. & Martinez, J. A. FTO obesity variant and adipocyte browning in humans. N. Engl. J. Med. 374, 190–191 (2016). · DOI
  67. Winkler, T. W. et al. The influence of age and sex on genetic associations with adult body size and shape: a large-scale genome-wide interaction study. PLoS Genet. 11, e1005378 (2015). · DOI
  68. Loche, E. & Ozanne, S. E. Early nutrition, epigenetics, and cardiovascular disease. Curr. Opin. Lipidol. 27, 449–458 (2016). · DOI
  69. Heijmans, B. T. et al. Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proc. Natl Acad. Sci. USA 105, 17046–17049 (2008). · DOI · Paper page
  70. Dick, K. J. et al. DNA methylation and body-mass index: a genome-wide analysis. Lancet 383, 1990–1998 (2014). · DOI · Paper page
  71. Jiang, C. et al. Disruption of hypoxia-inducible factor 1 in adipocytes improves insulin sensitivity and decreases adiposity in high-fat diet-fed mice. Diabetes 60, 2484–2495 (2011). · DOI
  72. Mendelson, M. M. et al. Association of body mass index with DNA methylation and gene expression in blood cells and relations to cardiometabolic disease: a Mendelian randomization approach. PLoS Med. 14, e1002215 (2017). · DOI
  73. van Dijk, S. J. et al. Epigenetics and human obesity. Int. J. Obes. (Lond.) 39, 85–97 (2015). This paper reports that unfavourable epigenomic profiles could be modified with appropriate lifestyle programmes. · DOI
  74. Giralt, M. & Villarroya, F. White, brown, beige/brite: different adipose cells for different functions? Endocrinology 154, 2992–3000 (2013). This paper suggests that understanding brown adipocyte activity and differentiation could be a useful tool to increase energy expenditure and the fight against obesity. · DOI · Paper page
  75. Sacks, H. & Symonds, M. E. Anatomical locations of human brown adipose tissue functional relevance and implications in obesity and type 2 diabetes. Diabetes 62, 1783–1790 (2013). · DOI
  76. Santhanam, P., Solnes, L., Hannukainen, J. C. & Taieb, D. Adiposity-related cancer and functional imaging of brown adipose tissue. Endocr. Pract. 21, 1282–1290 (2015). · DOI
  77. Prodhomme, H. et al. Imaging and identification of brown adipose tissue on CT scan. Clin. Physiol. Funct. Imaginghttp://dx.doi.org/10.1111/cpf.12373 (2016). · DOI
  78. Matsuzawa, Y. The metabolic syndrome and adipocytokines. FEBS Lett. 580, 2917–2921 (2006). · DOI
  79. Kotani, K. et al. Sexual dimorphism of age-related changes in whole-body fat distribution in the obese. Int. J. Obes. Relat. Metab. Disord. 18, 207–202 (1994).
  80. Rosen, E. D. & Spiegelman, B. M. What we talk about when we talk about fat. Cell 156, 20–44 (2014). · DOI · Paper page
  81. Gonzalez-Muniesa, P. et al. Effects of hyperoxia on oxygen-related inflammation with a focus on obesity. Oxid. Med. Cell. Longev. 2015, 8957827 (2015).
  82. Karpe, F. & Pinnick, K. E. Biology of upper-body and lower-body adipose tissue — link to whole-body phenotypes. Nat. Rev. Endocrinol. 11, 90–100 (2015). · DOI · Paper page
  83. Rosito, G. A. et al. Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart Study. Circulation 117, 605–613 (2008). · DOI · Paper page
  84. Thanassoulis, G. et al. Prevalence, distribution, and risk factor correlates of high pericardial and intrathoracic fat depots in the Framingham Heart Study. Circ. Cardiovasc. Imaging 3, 559–566 (2010). · DOI
  85. Thomas, E. L. et al. The missing risk: MRI and MRS phenotyping of abdominal adiposity and ectopic fat. Obesity (Silver Spring) 20, 76–87 (2012). This article defines a new subphenotype, called thin-on-the-outside fat-on-the-inside (TOFI), for individuals at increased metabolic risk. · DOI
  86. Ross, R. et al. Does the relationship between waist circumference, morbidity and mortality depend on measurement protocol for waist circumference? Obes. Rev. 9, 312–325 (2008). · DOI
  87. Neeland, I. J. et al. Body fat distribution and incident cardiovascular disease in obese adults. J. Am. Coll. Cardiol. 65, 2150–2151 (2015). · DOI
  88. Monajemi, H., Stroes, E., Hegele, R. A. & Fliers, E. Inherited lipodystrophies and the metabolic syndrome. Clin. Endocrinol. (Oxf.) 67, 479–484 (2007). · DOI
  89. Patni, N. & Garg, A. Congenital generalized lipodystrophies — new insights into metabolic dysfunction. Nat. Rev. Endocrinol. 11, 522–534 (2015). · DOI
  90. Iannucci, C. V., Capoccia, D., Calabria, M. & Leonetti, F. Metabolic syndrome and adipose tissue: new clinical aspects and therapeutic targets. Curr. Pharm. Des. 13, 2148–2168 (2007). · DOI
  91. Camilleri, M. Peripheral mechanisms in appetite regulation. Gastroenterology 148, 1219–1233 (2015). · DOI
  92. Ridaura, V. K. et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science 341, 1241214 (2013). · DOI · Paper page
  93. Santacruz, A. et al. Interplay between weight loss and gut microbiota composition in overweight adolescents. Obesity (Silver Spring) 17, 1906–1915 (2009). · DOI · Paper page
  94. Stenholm, S. et al. Sarcopenic obesity: definition, cause and consequences. Curr. Opin. Clin. Nutr. Metab. Care 11, 693–700 (2008). · DOI · Paper page
  95. Prado, C. M. et al. A population-based approach to define body-composition phenotypes. Am. J. Clin. Nutr. 99, 1369–1377 (2014). · DOI
  96. Teixeira, T. F., Alves, R. D., Moreira, A. P. & Peluzio Mdo, C. Main characteristics of metabolically obese normal weight and metabolically healthy obese phenotypes. Nutr. Rev. 73, 175–190 (2015). · DOI
  97. Hwang, Y. C. et al. Visceral abdominal fat accumulation predicts the conversion of metabolically healthy obese subjects to an unhealthy phenotype. Int. J. Obes. (Lond.) 39, 1365–1370 (2015). This paper provides data to differentiate between metabolically healthy obese and metabolically unhealthy obese, and the conversion from the former to the latter. · DOI
  98. Franco, L. P., Morais, C. C. & Cominetti, C. Normal-weight obesity syndrome: diagnosis, prevalence, and clinical implications. Nutr. Rev. 74, 558–570 (2016). · DOI
  99. Chan, J. C. et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA 301, 2129–2140 (2009). · DOI · Paper page
  100. Zheng, W. et al. Association between body-mass index and risk of death in more than 1 million Asians. N. Engl. J. Med. 364, 719–729 (2011). · DOI · Paper page
  101. Ortega, F. B., Sui, X., Lavie, C. J. & Blair, S. N. Body mass index, the most widely used but also widely criticized index: would a criterion standard measure of total body fat be a better predictor of cardiovascular disease mortality? Mayo Clin. Proc. 91, 443–455 (2016). · DOI
  102. Savva, S. C., Lamnisos, D. & Kafatos, A. G. Predicting cardiometabolic risk: waist-to-height ratio or BMI. A meta-analysis. Diabetes Metab. Syndr. Obes. 6, 403–419 (2013). · DOI
  103. Marques, M. et al. Design of the nutritional therapy for overweight and obese Spanish adolescents conducted by registered dieticians: the EVASYON study. Nutr. Hosp. 27, 165–176 (2012).
  104. Dong, B., Wang, Z., Wang, H. J. & Ma, J. Associations between adiposity indicators and elevated blood pressure among Chinese children and adolescents. J. Hum. Hypertens. 29, 236–240 (2015). · DOI
  105. Guo, F., Moellering, D. R. & Garvey, W. T. The progression of cardiometabolic disease: validation of a new cardiometabolic disease staging system applicable to obesity. Obesity (Silver Spring) 22, 110–118 (2014). · DOI · Paper page
  106. Sharma, A. M. & Kushner, R. F. A proposed clinical staging system for obesity. Int. J. Obes. (Lond.) 33, 289–295 (2009). · DOI · Paper page
  107. Heo, M., Faith, M. S., Pietrobelli, A. & Heymsfield, S. B. Percentage of body fat cutoffs by sex, age, and race-ethnicity in the US adult population from NHANES 1999–2004. Am. J. Clin. Nutr. 95, 594–602 (2012). · DOI · Paper page
  108. Blake-Lamb, T. L. et al. Interventions for childhood obesity in the first 1,000 days a systematic review. Am. J. Prev. Med. 50, 780–789 (2016). · DOI · Paper page
  109. Tanvig, M. et al. Anthropometrics and body composition by dual energy X-ray in children of obese women: a follow-up of a randomized controlled trial (the Lifestyle in Pregnancy and Offspring [LiPO] study). PLoS ONE 9, e89590 (2014). · DOI
  110. Wen, L. M. et al. Effectiveness of home based early intervention on children's BMI at age 2: randomised controlled trial. BMJ 344, e3732 (2012). · DOI · Paper page
  111. Navarro, J. I., Sigulem, D. M., Ferraro, A. A., Polanco, J. J. & Barros, A. J. The double task of preventing malnutrition and overweight: a quasi-experimental community-based trial. BMC Public Health 13, 212 (2013). · DOI
  112. Ciampa, P. J. et al. Interventions aimed at decreasing obesity in children younger than 2 years: a systematic review. Arch. Pediatr. Adolesc. Med. 164, 1098–1104 (2010). · DOI
  113. Summerbell, C. D. et al. Evidence-based recommendations for the development of obesity prevention programs targeted at preschool children. Obes. Rev. 13 (Suppl. 1), 129–132 (2012). · DOI
  114. Waters, E. et al. Interventions for preventing obesity in children. Cochrane Database Syst. Rev. 12, CD001871 (2011).
  115. Shah, R., Kennedy, S., Clark, M. D., Bauer, S. C. & Schwartz, A. Primary care-based interventions to promote positive parenting behaviors: a meta-analysis. Pediatrics 137, e20153393 (2016). · DOI
  116. Ewart-Pierce, E., Mejia Ruiz, M. J. & Gittelsohn, J. “Whole-of-community” obesity prevention: a review of challenges and opportunities in multilevel, multicomponent interventions. Curr. Obes. Rep. 5, 361–374 (2016). · DOI
  117. Gluckman, P., Nishtar, S. & Armstrong, T. Ending childhood obesity: a multidimensional challenge. Lancet 385, 1048–1050 (2015). · DOI
  118. Moreno, L. A. et al. Nutrition and lifestyle in European adolescents: the HELENA (Healthy Lifestyle in Europe by Nutrition in Adolescence) study. Adv. Nutr. 5, 615S–623S (2014). · DOI
  119. Garvey, W. T. et al. American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity: executive summary: complete guidelines available at https://www.aace.com/publications/guidelines. Endocr. Pract. 22, 842–884 (2016). · DOI · Paper page
  120. Jensen, M. D. et al. Executive summary: guidelines (2013) for the management of overweight and obesity in adults. Obesity 22, S5–S39 (2014). · DOI
  121. Yumuk, V., Fruhbeck, G., Oppert, J. M., Woodward, E. & Toplak, H. An EASO position statement on multidisciplinary obesity management in adults. Obes. Facts 7, 96–101 (2014). · DOI
  122. Wadden, T. A., Webb, V. L., Moran, C. H. & Bailer, B. A. Lifestyle modification for obesity: new developments in diet, physical activity, and behavior therapy. Circulation 125, 1157–1170 (2012). · DOI · Paper page
  123. Leblanc, E. S., O’Connor, E., Whitlock, E. P., Patnode, C. D. & Kapka, T. Effectiveness of primary care-relevant treatments for obesity in adults: a systematic evidence review for the U.S. Preventive Services Task Force. Ann. Intern. Med. 155, 434–447 (2011). · DOI · Paper page
  124. Robinson, E. et al. A systematic review and meta-analysis examining the effect of eating rate on energy intake and hunger. Am. J. Clin. Nutr. 100, 123–151 (2014). · DOI · Paper page
  125. Tate, D. F. A series of studies examining Internet treatment of obesity to inform Internet interventions for substance use and misuse. Subst. Use Misuse 46, 57–65 (2011). · DOI
  126. Johnston, B. C. et al. Comparison of weight loss among named diet programs in overweight and obese adults: a meta-analysis. JAMA 312, 923–933 (2014). · DOI · Paper page
  127. Abete, I., Astrup, A., Martínez, J. A., Thorsdottir, I. & Zulet, M. A. Obesity and the metabolic syndrome: role of different dietary macronutrient distribution patterns and specific nutritional components on weight loss and maintenance. Nutr. Rev. 68, 214–231 (2010). · DOI
  128. Solas, M., Milagro, F. I., Martinez-Urbistondo, D., Ramirez, M. J. & Martinez, J. A. Precision obesity treatments including pharmacogenetic and nutrigenetic approaches. Trends Pharmacol. Sci. 37, 575–593 (2016). · DOI
  129. Schauer, P. R. et al. Bariatric surgery versus intensive medical therapy for diabetes — 3-year outcomes. N. Engl. J. Med. 370, 2002–2013 (2014). · DOI · Paper page
  130. Sjostrom, L. Review of the key results from the Swedish Obese Subjects (SOS) trial — a prospective controlled intervention study of bariatric surgery. J. Intern. Med. 273, 219–234 (2013). · DOI · Paper page
  131. Ikramuddin, S. et al. Roux-en-Y gastric bypass versus intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial. JAMA 309, 2240–2249 (2013). · DOI · Paper page
  132. Nguyen, K. T. & Korner, J. The sum of many parts: potential mechanisms for improvement in glucose homeostasis after bariatric surgery. Curr. Diab. Rep. 14, 481 (2014). · DOI
  133. Colquitt, J. L., Pickett, K., Loveman, E. & Frampton, G. K. Surgery for weight loss in adults. Cochrane Database Syst. Rev. 8, CD003641 (2014).
  134. Chang, S. H. et al. The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003–2012. JAMA Surg. 149, 275–287 (2014). · DOI · Paper page
  135. Kroes, M., Osei-Assibey, G., Baker-Searle, R. & Huang, J. Impact of weight change on quality of life in adults with overweight/obesity in the United States: a systematic review. Curr. Med. Res. Opin. 32, 485–508 (2016). This paper reports that weight loss should improve quality of life in people who are overweight and obese. · DOI
  136. Perez-Cornago, A. et al. A decline in inflammation is associated with less depressive symptoms after a dietary intervention in metabolic syndrome patients: a longitudinal study. Nutr. J. 13, 36 (2014). · DOI
  137. Vallis, M. Quality of life and psychological well-being in obesity management: improving the odds of success by managing distress. Int. J. Clin. Pract. 70, 196–205 (2016). · DOI
  138. Groessl, E. J., Kaplan, R. M., Barrett-Connor, E. & Ganiats, T. G. Body mass index and quality of well-being in a community of older adults. Am. J. Prev. Med. 26, 126–129 (2004). · DOI
  139. Brazier, J., Jones, N. & Kind, P. Testing the validity of the Euroqol and comparing it with the SF-36 health survey questionnaire. Qual. Life Res. 2, 169–180 (1993). · DOI · Paper page
  140. Muennig, P., Lubetkin, E., Jia, H. & Franks, P. Gender and the burden of disease attributable to obesity. Am. J. Public Health 96, 1662–1668 (2006). · DOI
  141. Cameron, A. J. et al. A bi-directional relationship between obesity and health-related quality of life: evidence from the longitudinal AusDiab study. Int. J. Obes. (Lond.) 36, 295–303 (2012). · DOI
  142. Kolotkin, R. L., Crosby, R. D., Williams, G. R., Hartley, G. G. & Nicol, S. The relationship between health-related quality of life and weight loss. Obes. Res. 9, 564–571 (2001). · DOI
  143. Pan, A. et al. Changes in body weight and health-related quality of life: 2 cohorts of US women. Am. J. Epidemiol. 180, 254–262 (2014). · DOI
  144. Warkentin, L. M. et al. Weight loss required by the severely obese to achieve clinically important differences in health-related quality of life: two-year prospective cohort study. BMC Med. 12, 175 (2014). · DOI
  145. de Beer, M. et al. Health-related-quality-of-life in obese adolescents is decreased and inversely related to BMI. Acta Paediatr. 96, 710–714 (2007). · DOI
  146. Helseth, S., Haraldstad, K. & Christophersen, K. A. A cross-sectional study of health related quality of life and body mass index in a Norwegian school sample (8–18 years): a comparison of child and parent perspectives. Health Qual. Life Outcomes 13, 47 (2015). · DOI
  147. Tsiros, M. D. et al. Health-related quality of life in obese children and adolescents. Int. J. Obes. (Lond.) 33, 387–400 (2009). · DOI · Paper page
  148. Wille, N., Erhart, M., Petersen, C. & Ravens-Sieberer, U. The impact of overweight and obesity on health-related quality of life in childhood — results from an intervention study. BMC Public Health 8, 421 (2008). · DOI
  149. Goni, L., Cuervo, M., Milagro, F. I. & Martinez, J. A. Future perspectives of personalized weight loss interventions based on nutrigenetic, epigenetic, and metagenomic data. J. Nutr. 146, 905S–912S (2016). This paper suggests that personalized dietary treatments could benefit from the integration of nutrigenetic, epigenetic and metagenomic data. · DOI
  150. Giles-Corti, B. et al. City planning and population health: a global challenge. Lancet 388, 2912–2924 (2016). · DOI · Paper page
  151. Taheri, S. The link between short sleep duration and obesity: we should recommend more sleep to prevent obesity. Arch. Dis. Child. 91, 881–884 (2006). · DOI · Paper page
  152. Diaz-Gutierrez, J. et al. Living at higher altitude and incidence of overweight/obesity: prospective analysis of the SUN cohort. PLoS ONE 11, e0164483 (2016). · DOI
  153. Lopez-Pascual, A. et al. Living at a geographically higher elevation is associated with lower risk of metabolic syndrome: prospective analysis of the SUN cohort. Front. Physiol. 7, 658 (2016). · DOI
  154. Kelley, C. P., Sbrocco, G. & Sbrocco, T. Behavioral modification for the management of obesity. Prim. Care 43, 159–175 (2016). · DOI
  155. Enright, G. et al. Evaluating factors influencing the delivery and outcomes of an incentive-based behaviour change strategy targeting child obesity: protocol for a qualitative process and impact evaluation. BMJ Open 6, e012536 (2016). · DOI
  156. Kahn, R., Buse, J., Ferrannini, E. & Stern, M. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 28, 2289–2304 (2005). · DOI · Paper page
  157. Zulet, M. A. et al. The reduction of the metabolyc syndrome in Navarra-Spain (RESMENA-S) study: a multidisciplinary strategy based on chrononutrition and nutritional education, together with dietetic and psychological control. Nutr. Hosp. 26, 16–26 (2011).
  158. Brazier, J. E. et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ 305, 160–164 (1992). · DOI · Paper page
  159. McHorney, C. A., Ware, J. E. Jr & Raczek, A. E. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med. Care 31, 247–263 (1993). · DOI · Paper page
  160. Kolotkin, R. L. & Crosby, R. D. Psychometric evaluation of the impact of weight on quality of life-lite questionnaire (IWQOL-lite) in a community sample. Qual. Life Res. 11, 157–171 (2002). · DOI · Paper page
  161. Crosby, R. D., Kolotkin, R. L. & Williams, G. R. An integrated method to determine meaningful changes in health-related quality of life. J. Clin. Epidemiol. 57, 1153–1160 (2004). · DOI
  162. Wyrwich, K. W., Tierney, W. M., Babu, A. N., Kroenke, K. & Wolinsky, F. D. A comparison of clinically important differences in health-related quality of life for patients with chronic lung disease, asthma, or heart disease. Health Serv. Res. 40, 577–591 (2005). · DOI
  163. Janicke, D. M. et al. Systematic review and meta-analysis of comprehensive behavioral family lifestyle interventions addressing pediatric obesity. J. Pediatr. Psychol. 39, 809–825 (2014). · DOI · Paper page
  164. Modi, A. C. & Zeller, M. H. The IWQOL-Kids©: establishing minimal clinically important difference scores and test-retest reliability. Int. J. Pediatr. Obes. 6, e94–e96 (2011). · DOI
  165. Lai, C. S., Wu, J. C., Ho, C. T. & Pan, M. H. Chemoprevention of obesity by dietary natural compounds targeting mitochondrial regulation. Mol. Nutr. Food Res. 61, 1600721 (2017). · DOI
  166. De Fanti, B. A., Milagro, F. I., Lamas, O., Martinez-Anso, E. & Martinez, J. A. Immunomanipulation of appetite and body temperature through the functional mimicry of leptin. Obes. Res. 10, 833–837 (2002). · DOI
  167. De Fanti, B. A., Lamas, O., Milagro, F. I., Martinez-Anso, E. & Martinez, J. A. Immunoneutralization and anti-idiotype production: two-sided applications of leptin. Trends Immunol. 23, 180–181 (2002). This article reports on immunotherapy as an obesity treatment. · DOI
  168. Martinez-Fernandez, L., Laiglesia, L. M., Huerta, A. E., Martinez, J. A. & Moreno-Aliaga, M. J. Omega-3 fatty acids and adipose tissue function in obesity and metabolic syndrome. Prostaglandins Other Lipid Mediat. 121, 24–41 (2015). · DOI
  169. Arias, N. et al. A combination of resveratrol and quercetin induces browning in white adipose tissue of rats fed an obesogenic diet. Obesity (Silver Spring) 25, 111–121 (2017). · DOI
  170. Gonzalez-Muniesa, P. et al. Impact of intermittent hypoxia and exercise on blood pressure and metabolic features from obese subjects suffering sleep apnea-hypopnea syndrome. J. Physiol. Biochem. 71, 589–599 (2015). · DOI
  171. Quintero, P., Milagro, F., Campion, J. & Martinez, J. Impact of oxygen availability on body weight management. Med. Hypotheses 74, 901–907 (2010). · DOI
  172. Gonzalez-Muniesa, P., Milagro, F. I., Campion, J. & Martinez, J. A. Reduction in energy efficiency induced by expression of the uncoupling protein, UCP1, in mouse liver mitochondria. Int. J. Mol. Med. 17, 591–597 (2006).
  173. Marti, A., Larrarte, E., Novo, F. J., Garcia, M. & Martinez, J. A. UCP2 muscle gene transfer modifies mitochondrial membrane potential. Int. J. Obes. Relat. Metab. Disord. 25, 68–74 (2001). · DOI
  174. Cordero, P., Campion, J., Milagro, F. I., Marzo, F. & Martinez, J. A. Fat-to-glucose interconversion by hydrodynamic transfer of two glyoxylate cycle enzyme genes. Lipids Health Dis. 7, 49 (2008). · DOI
  175. Rolland-Cachera, M. F., Deheeger, M., Maillot, M. & Bellisle, F. Early adiposity rebound: causes and consequences for obesity in children and adults. Int. J. Obes. (Lond.) 30, S11–S17 (2006). · DOI
  176. Jensen, S. M., Ritz, C., Ejlerskov, K. T., Molgaard, C. & Michaelsen, K. F. Infant BMI peak, breastfeeding, and body composition at age 3y. Am. J. Clin. Nutr. 101, 319–325 (2015). · DOI
  177. Naik, R. D., Choksi, Y. A. & Vaezi, M. F. Consequences of bariatric surgery on oesophageal function in health and disease. Nat. Rev. Gastroenterol. Hepatol. 13, 111–119 (2016). · DOI
  178. Torgerson, J. S., Hauptman, J., Boldrin, M. N. & Sjostrom, L. XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care 27, 155–161 (2004). · DOI · Paper page
  179. Cefalu, W. T. et al. Advances in the science, treatment, and prevention of the disease of obesity: reflections from a Diabetes Care Editors’ Expert Forum. Diabetes Care 38, 1567–1582 (2015). · DOI

Cited by

See all 1,113

Metadata

Authors
González-Muniesa, P., Mártinez-González, M.-A., Hu, F. B., Després, J.-P., Matsuzawa, Y., Loos, R. J. F., Moreno, L. A., Bray, G. A., & Martinez, J. A.
Venue
Nature Reviews Disease Primers
Published
2017-06-15
Volume
3
Issue
1
Pages
17034-17034
ISSN
2056-676X (ISSN-L)
OpenAlex
W4211047194
Cited by
1,113
References
50
FWCI
16.19
Type
journal article
Language
en
Open access
closed
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.